Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04458532 · ClinicalTrials.gov registry record · NA
Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer
A NA study of Early Stage Breast Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 152
- Enrollment target
- 2
- Study locations
NCT04458532: Recruiting NA study of Early Stage Breast Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
NCT04458532 is a NA study of Early Stage Breast Cancer that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 152 participants, below the 407-participant average among 21 other Early Stage Breast Cancer trials with a reported enrollment target (63% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04458532, a NA study of Early Stage Breast Cancer, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 152 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study will compare the effects on cardiorespiratory fitness (CRF) of aerobic exercise in different amounts (number of minutes/session) over different periods of time (number of weeks). Aerobic exercise is physical activity of light-to-moderate intensity that uses the large muscle groups (muscles in your legs, buttocks, back, and chest) and can be performed for at least 10 minutes. The researchers will study the effects of different exercise programs on how well the study participants' bodies use oxygen, how well their heart pumps blood, how well their lungs function, and how healthy their blood vessels are.
Primary Outcome
A CRF change ≥1.32 ml O2.kg-1.min-1 will be considered a response; a change \<1.32 ml O2.kg-1.min-1 will be considered a non-response.
Conditions Studied
Interventions
- OTHER Aerobic Training
Study Locations (2)
Connecticut
- Hartford Healthcare Cancer Institute @ Hartford Hospital (Data Collection Only) - Hartford
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2020-10-08 |
| Est. Completion | 2027-03-31 |
| Phase | NA |
What NCT04458532 shows while recruiting
NCT04458532 is an interventional study that assigns participants to a tested intervention. The registered 152 participants enrollment target is mid-sized for trials with a published cap, below the 407-participant average among 21 other Early Stage Breast Cancer trials with a reported enrollment target (63% lower).
The record links to 1 condition, with Early Stage Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Aerobic Training is the first listed.
NCT04458532 reports a single indexed study location in Connecticut, New York.
Frequently Asked Questions
What is clinical trial NCT04458532 about?
NCT04458532 is a clinical study titled "Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer". This study will compare the effects on cardiorespiratory fitness (CRF) of aerobic exercise in different amounts (number of minutes/session) over different periods of time (number of weeks). Aerobic exercise is physical activity of light-to-moderate intensity that uses the large muscle groups (muscle...
What is the current status of trial NCT04458532?
This trial is currently recruiting. It is a NA study. The enrollment target is 152 participants. The study started on 2020-10-08. Estimated completion is 2027-03-31.
What conditions does trial NCT04458532 study?
This clinical trial studies the following conditions: Early Stage Breast Cancer.
What interventions are being tested in trial NCT04458532?
The interventions under investigation include: Aerobic Training (OTHER).
Who is sponsoring clinical trial NCT04458532?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04458532 being conducted?
This trial has 2 study locations across Connecticut, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Early Stage Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04458532's enrollment target sits among peer trials
152 5th of 21 higher than 17 of 21 other Early Stage Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Stage Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Portable Scalp Cooling System (PSCS) to Prevent Hair Loss for Breast Cancer Patients (Cooler Heads)
RECRUITING · NA
-
Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming
RECRUITING · NA
-
Cardiometabolic Screening Program
RECRUITING · NA
-
SABER Study for Selected Early Stage Breast Cancer
RECRUITING · NA
-
Outcomes and Cosmesis With Whole Breast Irradiation and Boost
RECRUITING · NA
-
POWER-remote Weight Loss Program in Early Stage Breast Cancer
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03328078 · 152 participants · Phase 1
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- NCT04858334 · 152 participants · Phase 2
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
- NCT04993859 · 152 participants
Impact of Chemotherapy on Urinary Biomarkers and Non-Invasive Urodynamics in Children
- NCT05176665 · 152 participants · Phase 1
EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI